Mercer et al. conducted a longitudinal study to determine the effects of HCQ (6.5 mg/kg/day) treatment for six weeks on insulin resistance, insulin sensitivity and pancreatic β-cell secretion of insulin in obese non-diabetic subjects (n=13; mean age: 49 ± 15 years). Here, INS is linked to Insulin resistance.